biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > so this new deal brings no volume or price movement

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Apr 15, 2022 3:40pm

152 Views

Post# 34606800

RE:RE:RE:so this new deal brings no volume or price movement

i may stink but the stock price stinks much worse. no volume or price appreciation on their recent "deal". even i thought the stock would move a little bit

Come back when you get a clue what kind of news will move BTI.

Or when you stop blaming others for your investment decisions.

Or when you stop sniveling and whining.

Or when you get a conscience.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles